Home › Funds › MEMBERS WEALTH LLC › DMAC
MEMBERS WEALTH LLC position in DMAC
DIAMEDICA THERAPEUTICS INC · Health Care
MEMBERS WEALTH LLC reported holding 101,382 shares of DMAC (DIAMEDICA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$810K, representing 0.40% of its reported portfolio and ranking #44 among its reported holdings. MEMBERS WEALTH LLC has disclosed DMAC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-20 · Source: SEC EDGAR Form 13F-HR
How MEMBERS WEALTH LLC's DMAC position evolved
MEMBERS WEALTH LLC first disclosed a stake in DMAC in Q4 2025 at 101,382 shares (US$864K). Across 4 filings, MEMBERS WEALTH LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 101,382 shares valued at US$810K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 101.38K | $864.28K | New |
| Q1 2026 | 101.38K | $655.94K | Hold |
| Q2 2026 | 101.38K | $713.73K | Hold |
| Q3 2026 | 101.38K | $810.04K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DMAC and 13F data
DMAC (DIAMEDICA THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in DMAC — the largest reported positions include COOPERMAN LEON G (US$24.3M), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (US$5.9M), Bleichroeder LP (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DMAC
- COOPERMAN LEON G 3.45M sh · $24.29M · Q2 2026
- PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 875.00K sh · $5.92M · Q1 2026
- Bleichroeder LP 382.32K sh · $2.69M · Q2 2026
- COBALT CAPITAL MANAGEMENT, INC. 90.00K sh · $633.60K · Q2 2026
More on MEMBERS WEALTH LLC
FAQ
How long has MEMBERS WEALTH LLC held DMAC?
MEMBERS WEALTH LLC has disclosed DMAC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is MEMBERS WEALTH LLC's current position in DMAC?
As of Q3 2026, MEMBERS WEALTH LLC holds 101.38K shares of DMAC (DIAMEDICA THERAPEUTICS INC), valued at $810.04K, representing 0.40% of its reported portfolio and ranking #44.
Has MEMBERS WEALTH LLC been buying or selling DMAC?
In the latest 13F filing (Q3 2026), MEMBERS WEALTH LLC held unchanged its position in DMAC.
Which other funds hold DMAC?
Other major institutional holders of DMAC include COOPERMAN LEON G, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, Bleichroeder LP, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.